Regulation of ubiquitin-proteasome system-mediated Tip110 protein degradation by USP15

International Journal of Biochemistry and Cell Biology

Volumn 54, Issue , 2014, Pages 10-19

  Timani, Khalid Amine ^a   Liu, Ying ^a   Suvannasankha, Attaya ^b   He, Johnny J ^a  

^a UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Protein degradation; Tip110 SART3; Ubiquitin proteasome system; USP15

Indexed keywords

ANGIOMOTIN ISOFORM 1; BCL 2 ASSOCIATED TRANSCRIPTION FACTOR 1 ISOFORM 1; DESMOGLEIN 2; DEUBIQUITINASE; HYPOXIA UP REGULATED PROTEIN 1 PRECURSOR; HYROID HORMONE RECEPTOR-ASSOCIATED PROTEIN; ISOLEUCINE TRANSFER RNA LIGASE; KIAA0603 PROTEIN; LEUCINE RICH PPR MOTIF CONTAINING PROTEIN; MESSENGER RNA; NEUROFILAMENT M PROTEIN; NUCLEAR DNA HELICASE II; NUCLEOPORIN 160 KDA ISOFORM CRA A; PROTEASOME; PROTEASOME INHIBITOR; PROTEIN; RAB1A PROTEIN; SPLICEOSOMAL PROTEIN SAP 155; TIP110 PROTEIN; UBIQUITIN; UBIQUITIN B ISOFORM CRA E; UBIQUITIN CARBOXYL TERMINAL HYDROLASE 15; UNCLASSIFIED DRUG; USP15 PROTEIN; VALINE TRANSFER RNA LIGASE; NUCLEAR PROTEIN; PROTEIN TIP110; PROTEIN USP15; TRANSACTIVATOR PROTEIN; RNA BINDING PROTEIN; SART3 PROTEIN, HUMAN; SMALL INTERFERING RNA; TUMOR ANTIGEN; USP15 PROTEIN, MOUSE;

AFFINITY CHROMATOGRAPHY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL NUCLEUS; COMPLEX FORMATION; CYTOPLASM; EMBRYO CELL; ENZYME REGULATION; FIBROBLAST; GENE EXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; IN VIVO STUDY; MOUSE; NONHUMAN; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEOMICS; REGULATORY MECHANISM; TRANSGENIC MOUSE; UBIQUITINATION; EMBRYO; TRANSGENE; 3T3 CELL LINE; ANIMAL; ANTAGONISTS AND INHIBITORS; C57BL MOUSE; CELL PROLIFERATION; FEMALE; GENETICS; HEK293 CELL LINE; IMMUNOPRECIPITATION; MALE; METABOLISM; PHYSIOLOGY; PROTEIN PROCESSING; WESTERN BLOTTING;

MUS MUSCULUS;

ANIMALS; ANTIGENS, NEOPLASM; BLOTTING, WESTERN; CELL PROLIFERATION; CYTOPLASM; FEMALE; HEK293 CELLS; HUMANS; IMMUNOPRECIPITATION; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; NIH 3T3 CELLS; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEOLYSIS; RNA, SMALL INTERFERING; RNA-BINDING PROTEINS; UBIQUITIN-SPECIFIC PROTEASES; UBIQUITINATION; UBIQUITINS;

EID: 84904195708     PISSN: 13572725     EISSN: 18785875     Source Type: Journal    
DOI: 10.1016/j.biocel.2014.06.017     Document Type: Article

References (61)

1. J. Adams, and M. Kauffman Development of the proteasome inhibitor Velcade (Bortezomib) Cancer Invest 22 2004 304 311 (Pubitemid 38725184)
2. A.Y. Amerik, and M. Hochstrasser Mechanism and function of deubiquitinating enzymes Biochim Biophys Acta 1695 2004 189 207 (Pubitemid 39574973)
3. M. Bell, S. Schreiner, A. Damianov, and R. Reddy Bindereif A. p110, a novel human U6 snRNP protein and U4/U6 snRNP recycling factor Embo J 21 2002 2724 2735 (Pubitemid 34619388)
4. A. Ciechanover Proteolysis: from the lysosome to ubiquitin and the proteasome Nat Rev Mol Cell Biol 6 2005 79 87
5. P.J. Eichhorn, L. Rodon, A. Gonzalez-Junca, A. Dirac, M. Gili, and E. Martinez-Saez et al. USP15 stabilizes TGF-beta receptor I and promotes oncogenesis through the activation of TGF-beta signaling in glioblastoma Nat Med 18 2012 429 435
6. K. Fukuda Expression of the SART3 antigens in oral cancers Kurume Med J 48 2001 55 58 (Pubitemid 33606572)
7. T. Fukuda, Y. Mishina, M.P. Walker, and R.P. DiAugustine Conditional transgenic system for mouse aurora a kinase: degradation by the ubiquitin proteasome pathway controls the level of the transgenic protein Mol Cell Biol 25 2005 5270 5281 (Pubitemid 40781123)
8. J. Gu, S. Shimba, N. Nomura, and R. Reddy Isolation and characterization of a new 110 kDa human nuclear RNA-binding protein (p110nrb) Biochim Biophys Acta 1399 1998 1 9 (Pubitemid 28374909)
9. K. Harada, A. Yamada, D. Yang, K. Itoh, and S. Shichijo Binding of a SART3 tumor-rejection antigen to a pre-mRNA splicing factor RNPS1: a possible regulation of splicing by a complex formation Int J Cancer 93 2001 623 628 (Pubitemid 32695108)
10. S.D. Hayes, H. Liu, E. MacDonald, C.M. Sanderson, J.M. Coulson, and M.J. Clague et al. Direct and indirect control of mitogen-activated protein kinase pathway-associated components, BRAP/IMP E3 ubiquitin ligase and CRAF/RAF1 kinase, by the deubiquitylating enzyme USP15 J Biol Chem 287 2012 43007 43018
11. A. Hershko, and A. Ciechanover The ubiquitin system Annu Rev Biochem 67 1998 425 479 (Pubitemid 28411135)
12. B.K. Hetfeld, A. Helfrich, B. Kapelari, H. Scheel, K. Hofmann, and A. Guterman et al. The zinc finger of the CSN-associated deubiquitinating enzyme USP15 is essential to rescue the E3 ligase Rbx1 Curr Biol 15 2005 1217 1221 (Pubitemid 40950520)
13. X. Huang, C. Langelotz, B.K. Hetfeld-Pechoc, W. Schwenk, and W. Dubiel The COP9 signalosome mediates beta-catenin degradation by deneddylation and blocks adenomatous polyposis coli destruction via USP15 J Mol Biol 391 2009 691 702
14. S. Hussain, Y. Zhang, and P.J. Galardy DUBs and cancer: the role of deubiquitinating enzymes as oncogenes, non-oncogenes and tumor suppressors Cell Cycle 8 2009 1688 1697
15. M. Inui, A. Manfrin, A. Mamidi, G. Martello, L. Morsut, and S. Soligo et al. USP15 is a deubiquitylating enzyme for receptor-activated SMADs Nat Cell Biol 13 2011 1368 1375
16. K. Iseki, H. Matsunaga, N. Komatsu, S. Suekane, M. Noguchi, and K. Itoh et al. Evaluation of a new oil adjuvant for use in peptide-based cancer vaccination Cancer Sci 101 2010 2110 2114
17. N. Kawagoe, I. Shintaku, S. Yutani, H. Etoh, K. Matuoka, and S. Noda et al. Expression of the SART3 tumor rejection antigen in renal cell carcinoma J Urol 164 2000 2090 2095
18. Y. Komohara, M. Harada, Y. Arima, S. Suekane, M. Noguchi, and A. Yamada et al. Anti-cancer vaccine candidates in specific immunotherapy for bladder carcinoma Int J Oncol 29 2006 1555 1560
19. D. Kornitzer, and A. Ciechanover Modes of regulation of ubiquitin-mediated protein degradation J Cell Physiol 182 2000 1 11 (Pubitemid 129710494)
20. D.H. Lee, and A.L. Goldberg Proteasome inhibitors: valuable new tools for cell biologists Trends Cell Biol 8 1998 397 403 (Pubitemid 28458705)
21. X. Li, and P. Coffino Degradation of ornithine decarboxylase: exposure of the C-terminal target by a polyamine-inducible inhibitory protein Mol Cell Biol 13 1993 2377 2383 (Pubitemid 23097716)
22. Y. Liu, B.O. Kim, C. Kao, C. Jung, J.T. Dalton, and J.J. He Tip110, the human immunodeficiency virus type 1 (HIV-1) Tat-interacting protein of 110 kDa as a negative regulator of androgen receptor (AR) transcriptional activation J Biol Chem 279 2004 21766 21773 (Pubitemid 38679363)
23. Y. Liu, M.R. Lee, K. Timani, J.J. He, and H.E. Broxmeyer Tip110 maintains expression of pluripotent factors in and pluripotency of human embryonic stem cells Stem Cells Dev 21 2012 829 833
24. Y. Liu, J. Li, B.O. Kim, B.S. Pace, and J.J. He HIV-1 Tat protein-mediated transactivation of the HIV-1 long terminal repeat promoter is potentiated by a novel nuclear Tat-interacting protein of 110 kDa, Tip110 J Biol Chem 277 2002 23854 23863 (Pubitemid 34952230)
25. Y. Liu, K. Timani, C. Mantel, Y. Fan, G. Hangoc, and S. Cooper et al. TIP110/p110nrb/SART3/p110 regulation of hematopoiesis through CMYC Blood 117 2011 5643 5651
26. Y. Liu, K. Timani, X. Ou, H.E. Broxmeyer, and J.J. He C-MYC controlled TIP110 protein expression regulates OCT4 mRNA splicing in human embryonic stem cells Stem Cells Dev 22 2013 689 694
27. L. Long, J.P. Thelen, M. Furgason, M. Haj-Yahya, A. Brik, and D. Cheng et al. The U4/U6 recycling factor SART3 has histone chaperone activity and associates with USP15 to regulate H2B deubiquitination J Biol Chem 289 2014 8916 8930
28. A. Mani, and E.P. Gelmann The ubiquitin-proteasome pathway and its role in cancer J Clin Oncol 23 2005 4776 4789 (Pubitemid 46224082)
29. L. Meng, R. Mohan, B.H. Kwok, M. Elofsson, N. Sin, and C.M. Crews Epoxomicin, a potent and selective proteasome inhibitor, exhibits in vivo antiinflammatory activity Proc Natl Acad Sci U S A 96 1999 10403 10408 (Pubitemid 29422570)
30. A.B. Meriin, V.L. Gabai, J. Yaglom, V.I. Shifrin, and M.Y. Sherman Proteasome inhibitors activate stress kinases and induce Hsp72. Diverse effects on apoptosis J Biol Chem 273 1998 6373 6379 (Pubitemid 28144729)
31. K. Murayama, T. Kobayashi, T. Imaizumi, K. Matsunaga, T. Kuramoto, and M. Shigemori et al. Expression of the SART3 tumor-rejection antigen in brain tumors and induction of cytotoxic T lymphocytes by its peptides J Immunother 23 2000 511 518
32. F. Niiya, S. Nishizaka, K. Matsunaga, K. Koufuji, M. Mori, and H. Katai et al. Expression of SART3 tumor-rejection antigen in gastric cancers Jpn J Cancer Res 91 2000 337 342 (Pubitemid 30198175)
33. S.M. Nijman, M.P. Luna-Vargas, A. Velds, T.R. Brummelkamp, A.M. Dirac, and T.K. Sixma et al. A genomic and functional inventory of deubiquitinating enzymes Cell 123 2005 773 786 (Pubitemid 41721026)
34. I. Novotny, M. Blazikova, D. Stanek, P. Herman, and J. Malinsky In vivo kinetics of U4/U6.U5 tri-snRNP formation in Cajal bodies Mol Biol Cell 22 2011 513 523
35. K.S. Richardson, and W. Zundel The emerging role of the COP9 signalosome in cancer Mol Cancer Res 3 2005 645 653 (Pubitemid 43042994)
36. P.G. Richardson, T. Hideshima, and K.C. Anderson Bortezomib (PS-341): a novel, first-in-class proteasome inhibitor for the treatment of multiple myeloma and other cancers Cancer Control 10 2003 361 369 (Pubitemid 37296062)
37. J.J. Sacco, J.M. Coulson, M.J. Clague, and S. Urbe Emerging roles of deubiquitinases in cancer-associated pathways IUBMB Life 62 2010 140 157
38. K. Schweitzer, P.M. Bozko, W. Dubiel, and M. Naumann CSN controls NF-kappaB by deubiquitinylation of IkappaBalpha Embo J 26 2007 1532 1541 (Pubitemid 46480929)
39. C.R. Sihn, S.Y. Cho, J.H. Lee, T.R. Lee, and S.H. Kim Mouse homologue of yeast Prp19 interacts with mouse SUG1, the regulatory subunit of 26S proteasome Biochem Biophys Res Commun 356 2007 175 180 (Pubitemid 46413146)
40. N. Sin, K.B. Kim, M. Elofsson, L. Meng, H. Auth, and B.H. Kwok et al. Total synthesis of the potent proteasome inhibitor epoxomicin: a useful tool for understanding proteasome biology Bioorg Med Chem Lett 9 1999 2283 2288 (Pubitemid 29371952)
41. T.A. Soboleva, D.A. Jans, M. Johnson-Saliba, and R.T. Baker Nuclear-cytoplasmic shuttling of the oncogenic mouse UNP/USP4 deubiquitylating enzyme J Biol Chem 280 2005 745 752 (Pubitemid 40165043)
42. E.J. Song, S.L. Werner, J. Neubauer, F. Stegmeier, J. Aspden, and D. Rio et al. The Prp19 complex and the Usp4Sart3 deubiquitinating enzyme control reversible ubiquitination at the spliceosome Genes Dev 24 2010 1434 1447
43. M.E. Sowa, E.J. Bennett, S.P. Gygi, and J.W. Harper Defining the human deubiquitinating enzyme interaction landscape Cell 138 2009 389 403
44. D. Stanek, S.D. Rader, M. Klingauf, and K.M. Neugebauer Targeting of U4/U6 small nuclear RNP assembly factor SART3/p110 to Cajal bodies J Cell Biol 160 2003 505 516 (Pubitemid 36254389)
45. Y. Suefuji, T. Sasatomi, S. Shichijo, S. Nakagawa, H. Deguchi, and T. Koga et al. Expression of SART3 antigen and induction of CTLs by SART3-derived peptides in breast cancer patients Br J Cancer 84 2001 915 919 (Pubitemid 32385834)
46. N. Suzuki, Y. Maeda, S. Tanaka, N. Hida, T. Mine, and K. Yamamoto et al. Detection of peptide-specific cytotoxic T-lymphocyte precursors used for specific immunotherapy of pancreatic cancer Int J Cancer 98 2002 45 50 (Pubitemid 34113417)
47. S. Tanaka, N. Tsuda, K. Kawano, M. Sakamoto, T. Nishida, and T. Hashimoto et al. Expression of tumor-rejection antigens in gynecologic cancers Jpn J Cancer Res 91 2000 1177 1184
48. K.A. Timani, Y. Liu, and J.J. He Tip110 interacts with YB-1 and regulates each other's function BMC Mol Biol 14 2013 14
49. N.S. Trede, J. Medenbach, A. Damianov, L.H. Hung, G.J. Weber, and B.H. Paw et al. Network of coregulated spliceosome components revealed by zebrafish mutant in recycling factor p110 Proc Natl Acad Sci U S A 104 2007 6608 6613 (Pubitemid 47175548)
50. S. Tsubuki, Y. Saito, M. Tomioka, H. Ito, and S. Kawashima Differential inhibition of calpain and proteasome activities by peptidyl aldehydes of di-leucine and tri-leucine J Biochem 119 1996 572 576 (Pubitemid 26100945)
51. N. Tsuda, K. Murayama, H. Ishida, K. Matsunaga, S. Komiya, and K. Itoh et al. Expression of a newly defined tumor-rejection antigen SART3 in musculoskeletal tumors and induction of HLA class I-restricted cytotoxic T lymphocytes by SART3-derived peptides J Orthop Res 19 2001 346 351 (Pubitemid 32472002)
52. K.H. Ventii, N.S. Devi, K.L. Friedrich, T.A. Chernova, M. Tighiouart, and E.G. Van Meir et al. BRCA1-associated protein-1 is a tumor suppressor that requires deubiquitinating activity and nuclear localization Cancer Res 68 2008 6953 6962
53. N.F. Villeneuve, W. Tian, T. Wu, Z. Sun, A. Lau, and E. Chapman et al. USP15 negatively regulates Nrf2 through deubiquitination of Keap1 Mol Cell 51 2013 68 79
54. A. von Mikecz The nuclear ubiquitin-proteasome system J Cell Sci 119 2006 1977 1984
55. R.M. Vos, J. Altreuter, E.A. White, and P.M. Howley The ubiquitin-specific peptidase USP15 regulates human papillomavirus type 16 E6 protein stability J Virol 83 2009 8885 8892
56. N. Wei, G. Serino, and X.W. Deng The COP9 signalosome: more than a protease Trends Biochem Sci 33 2008 592 600
57. K.D. Wilkinson Regulation of ubiquitin-dependent processes by deubiquitinating enzymes FASEB J 11 1997 1245 1256 (Pubitemid 27527888)
58. M. Xu, M. Takanashi, K. Oikawa, M. Tanaka, H. Nishi, and K. Isaka et al. USP15 plays an essential role for caspase-3 activation during Paclitaxel-induced apoptosis Biochem Biophys Res Commun 388 2009 366 371
59. D. Yang, M. Nakao, S. Shichijo, T. Sasatomi, H. Takasu, and H. Matsumoto et al. Identification of a gene coding for a protein possessing shared tumor epitopes capable of inducing HLA-A24-restricted cytotoxic T lymphocytes in cancer patients Cancer Res 59 1999 4056 4063 (Pubitemid 29393577)
60. D.D. Zhang, S.C. Lo, Z. Sun, G.M. Habib, M.W. Lieberman, and M. Hannink Ubiquitination of Keap1, a BTB-Kelch substrate adaptor protein for Cul3, targets Keap1 for degradation by a proteasome-independent pathway J Biol Chem 280 2005 30091 30099 (Pubitemid 41216185)
61. W. Zhao, Y. Liu, K.A. Timani, and J.J. He Tip110 protein binds to unphosphorylated RNA polymerase II and promotes its phosphorylation and HIV-1 long terminal repeat transcription J Biol Chem 289 2014 190 202